Islam M. Ghazi

461 total citations
35 papers, 320 citations indexed

About

Islam M. Ghazi is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Islam M. Ghazi has authored 35 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Medicine, 15 papers in Pharmacology and 15 papers in Epidemiology. Recurrent topics in Islam M. Ghazi's work include Antibiotic Resistance in Bacteria (17 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Antibiotic Use and Resistance (8 papers). Islam M. Ghazi is often cited by papers focused on Antibiotic Resistance in Bacteria (17 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Antibiotic Use and Resistance (8 papers). Islam M. Ghazi collaborates with scholars based in United States, Oman and United Arab Emirates. Islam M. Ghazi's co-authors include David P. Nicolau, Masakatsu Tsuji, Marguerite L. Monogue, Wasim S. El Nekidy, Ahmad Omar, Laura Pontiggia, Mohamad Mooty, Mordechai Grupper, Patrick McGann and Emil Lesho and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Infection Control and Hospital Epidemiology.

In The Last Decade

Islam M. Ghazi

33 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Islam M. Ghazi United States 10 197 129 101 96 45 35 320
David van Veenhuyzen United States 5 254 1.3× 208 1.6× 121 1.2× 130 1.4× 40 0.9× 7 392
Phillip Chung United States 5 226 1.1× 159 1.2× 87 0.9× 106 1.1× 41 0.9× 10 335
Yuag-Meng Liu Taiwan 8 193 1.0× 68 0.5× 89 0.9× 131 1.4× 50 1.1× 8 358
Xing Tan United States 9 184 0.9× 120 0.9× 69 0.7× 85 0.9× 55 1.2× 19 290
Cláudia Murta de Oliveira United States 6 236 1.2× 172 1.3× 125 1.2× 143 1.5× 31 0.7× 6 372
Robert A Bonomo United States 2 266 1.4× 148 1.1× 115 1.1× 91 0.9× 37 0.8× 4 381
Mónica Gozalo Spain 4 184 0.9× 54 0.4× 80 0.8× 112 1.2× 51 1.1× 6 280
Christopher Blunden United States 5 172 0.9× 74 0.6× 93 0.9× 64 0.7× 24 0.5× 7 240
Christophe Le Terrier Switzerland 13 233 1.2× 137 1.1× 70 0.7× 89 0.9× 73 1.6× 38 409
Pavithra Srinivas United States 9 208 1.1× 137 1.1× 72 0.7× 96 1.0× 59 1.3× 23 416

Countries citing papers authored by Islam M. Ghazi

Since Specialization
Citations

This map shows the geographic impact of Islam M. Ghazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Islam M. Ghazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Islam M. Ghazi more than expected).

Fields of papers citing papers by Islam M. Ghazi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Islam M. Ghazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Islam M. Ghazi. The network helps show where Islam M. Ghazi may publish in the future.

Co-authorship network of co-authors of Islam M. Ghazi

This figure shows the co-authorship network connecting the top 25 collaborators of Islam M. Ghazi. A scholar is included among the top collaborators of Islam M. Ghazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Islam M. Ghazi. Islam M. Ghazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nekidy, Wasim S. El, Islam M. Ghazi, Rania M. El-Lababidi, et al.. (2024). Clinical Outcomes of Trimethoprim/Sulfamethoxazole in Critically Ill Patients with Stenotrophomonas maltophilia Bacteremia and Pneumonia Utilizing Renal Replacement Therapies. Journal of Clinical Medicine. 13(8). 2275–2275. 1 indexed citations
3.
4.
Nekidy, Wasim S. El, et al.. (2023). Microbiologic outcomes of ceftazidime‐avibactam dosing in patients with sepsis utilizing renal replacement therapies. Hemodialysis International. 27(3). 289–295. 4 indexed citations
5.
Nekidy, Wasim S. El, Jihad Mallat, Ahmad Nusair, et al.. (2022). Urinary tract infections in hemodialysis patients—The controversy of antimicrobial drug urine concentrations. Hemodialysis International. 26(4). 548–554.
6.
Nekidy, Wasim S. El, et al.. (2021). Risk Factors for Recurrence of Clostridioides difficile in Hospitalized Patients. Journal of Infection and Public Health. 14(11). 1642–1649. 15 indexed citations
7.
Ghazi, Islam M., et al.. (2020). Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach. PLoS ONE. 15(5). e0233335–e0233335. 7 indexed citations
8.
Ghazi, Islam M., et al.. (2020). Y-site Administration of Imipenem/Cilastatin/Relebactam With Common Intravenous Medications. Clinical Therapeutics. 42(3). 475–485. 5 indexed citations
9.
Pontiggia, Laura, et al.. (2020). Multi-drug resistant Acinetobacter baumannii infection, risk factors for mortality. International Journal of Infectious Diseases. 101. 158–158. 1 indexed citations
10.
11.
Nekidy, Wasim S. El, et al.. (2020). Optimal vancomycin dose in the treatment of Clostridium difficile infection, antimicrobial stewardship initiative. Journal of Chemotherapy. 33(3). 165–173. 4 indexed citations
12.
Nekidy, Wasim S. El, et al.. (2020). Ertapenem Neurotoxicity in Hemodialysis Patients—Safe and Effective Dosing Is Still Needed: A Retrospective Study and Literature Review. Annals of Pharmacotherapy. 55(1). 52–58. 6 indexed citations
13.
Pontiggia, Laura, et al.. (2019). Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program. International Journal of Infectious Diseases. 83. 77–82. 16 indexed citations
14.
Ghazi, Islam M., Marguerite L. Monogue, Masakatsu Tsuji, & David P. Nicolau. (2018). Humanized Exposures of Cefiderocol, a Siderophore Cephalosporin, Display Sustained in vivo Activity against Siderophore-Resistant <b><i>Pseudomonas aeruginosa</i></b>. Pharmacology. 101(5-6). 278–284. 38 indexed citations
15.
Nekidy, Wasim S. El, et al.. (2018). Salvage of Hemodialysis Catheter in Staphylococcal Bacteremia: Case Series, Revisiting the Literature, and the Role of the Pharmacist. Case Reports in Nephrology and Dialysis. 8(2). 121–129. 10 indexed citations
16.
17.
Ghazi, Islam M., Marguerite L. Monogue, Masakatsu Tsuji, & David P. Nicolau. (2017). Pharmacodynamics of cefiderocol, a novel siderophore cephalosporin, in a Pseudomonas aeruginosa neutropenic murine thigh model. International Journal of Antimicrobial Agents. 51(2). 206–212. 45 indexed citations
18.
Ghazi, Islam M., David P. Nicolau, Michael D. Nailor, et al.. (2016). Antibiotic Utilization and Opportunities for Stewardship Among Hospitalized Patients With Influenza Respiratory Tract Infection. Infection Control and Hospital Epidemiology. 37(5). 583–589. 19 indexed citations
19.
Ghazi, Islam M., Jared L. Crandon, Emil Lesho, Patrick McGann, & David P. Nicolau. (2016). In vivo efficacy of humanized high dose meropenem and comparators against Pseudomonas aeruginosa isolates producing verona integron-encoded metallo-β-lactamase (VIM). Heliyon. 2(6). e00121–e00121. 2 indexed citations
20.
Ghazi, Islam M., et al.. (1991). [Maxillary cyst of dental origin with uncommon ocular complication].. PubMed. 14(1). 32–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David van Veenhuyzen Breakdown of academic impact, for papers by Phillip Chung Breakdown of academic impact, for papers by Yuag-Meng Liu Breakdown of academic impact, for papers by Xing Tan Breakdown of academic impact, for papers by Cláudia Murta de Oliveira Breakdown of academic impact, for papers by Robert A Bonomo Breakdown of academic impact, for papers by Mónica Gozalo Breakdown of academic impact, for papers by Christopher Blunden Breakdown of academic impact, for papers by Christophe Le Terrier Breakdown of academic impact, for papers by Pavithra Srinivas
Rankless by CCL
2026